Niraparib - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Indazolecarboxamide owl:NamedIndividual Orphan drug Piperidine PARP inhibitor GSK plc brand Drug granted breakthrough therapy designation
rdfs:label	Niraparib
owl:sameAs	dbr:Niraparib
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Tesaro http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/Category:Piperidines http://en.wikipedia.org/wiki/Category:Indazolecarboxamides http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:PARP_inhibitors http://en.wikipedia.org/wiki/PARP_inhibitor http://en.wikipedia.org/wiki/Category:GSK_plc_brands
skos:prefLabel	Niraparib
skos:altLabel	niraparib
clgo:alternativeName	Zejula
clgo:bioavailability	73.0
clgo:casNumber	1038915-60-4
clgo:chEBI	176844
clgo:chEMBL	1094636
clgo:drugbank	DB11793
clgo:fdaUniiCode	HMC2H89N35
clgo:kegg	D10140 D11895
clgo:medlinePlus	a617007
clgo:pubchem	24958200
is clgo:medication of	Cystadenocarcinoma

About: clgr:Niraparib